Skip to Main Content

Paper Details

Metabolites as Prognostic Markers for Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Platinum-Doublet Chemotherapy.
Cancers (Basel)
8
2020
Author NameAffiliation
Keyue DingQueen's University
Frances A ShepherdUniversity Health Network, Princess Margaret Cancer Centre, University Avenue
Aalim M WeljiePerelman School of Medicine at the University of Pennsylvania
  • 1 - 3

Datasets

Release 1.2